Skip to content
AwardedFranceGoods

MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CARBOXYMALTOSE FERRIQUE ET CIPROFLOXACINE INJECTABLE

Published
Published 9 December 2025

Overview

MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CARBOXYMALTOSE FERRIQUE ET CIPROFLOXACINE INJECTABLE

Key details

Country
France
Status
Awarded
Category
Goods
Procedure
Direct
Published
9 December 2025
Classification (CPV)
Various medicinal products

Award outcome

Award date
25 November 2025
Contract period
1 December 2025 → 31 May 2026
Winner
  • VIFOR FRANCE SA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    9 December 2025

Contracting authority

  • Centre Hospitalier de Valenciennes

    Procuring entity

    Valenciennes cedex, France

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CARBOXYMALTOSE FERRIQUE ET CIPROFLOXACINE INJECTABLE — won by VIFOR FRANCE SA — Skim